TROY, Mich., Nov. 4 /PRNewswire-FirstCall/ -- Somanetics Corporation announced that president and chief executive officer Bruce J. Barrett will present at the Noble Financial Group Small Cap Conference being held November 10-11, 2005 at the Hard Rock Hotel & Casino in Hollywood, Florida. Mr. Barrett’s presentation, scheduled for 2:15 p.m. ET on Thursday, November 10, 2005, will discuss Somanetics’ recent accomplishments and opportunities in the high-risk surgical and intensive care unit markets.
Somanetics’ presentation will be webcast live and may be accessed by visiting the Investor Relations section of Somanetics’ website at http://www.somanetics.com or Noble Financial Group’s site at http://www.noblefinancialgroup.com/smallcaprock.htm . The presentation also will be archived on Somanetics’ website for 90 days following the conference.
Noble Financial Group specializes in small-cap equity research providing institutional investors with detailed corporate analysis, sector and industry studies, road shows, investment banking, market-making, and sales and trading services. The conference will feature approximately fifty companies across numerous industry sectors.
About Somanetics
Somanetics develops and markets the INVOS(R) Cerebral Oximeter, which occupies a unique position in U.S. hospitals as the only commercially available monitoring system that noninvasively and continuously monitors changes in a patient’s regional brain blood oxygen saturation. Use of the INVOS Cerebral Oximeter helps medical professionals, such as surgeons, anesthesiologists, perfusionists and the critical care team, identify regional brain blood oxygen imbalances and take corrective action. Such action can prevent or reduce neurological injuries related to adverse events during surgery or in the critical care unit and reduce the associated cost of care. Somanetics also markets the CorRestore(R) System, a cardiac implant used in cardiac repair and reconstruction, including an operation called Surgical Ventricular Restoration, or SVR, a surgical treatment for patients with certain types of severe congestive heart failure. Somanetics’ web site is http://www.somanetics.com .
Somanetics Corporation
CONTACT: Mary Ann Victor, Vice President, Communications of SomaneticsCorporation, +1-248-689-3050, ext. 204
Web site: http://www.somanetics.com/
